| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
John E Kao is Chief Executive Officer at ALHC. John E Kao's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.4M at current prices.
Our model assigns John E Kao a middling insider score of 68/100, based on 57 past trades. Over a 12-month horizon, 63.4% of those trades were profitable, with an average 12-month return of +17.9%.
The ALHC filings lean toward selling, a net 8,398,692 shares.
John E Kao has 58 Form 4 filings on record from October 2021 to September 2026, all as Chief Executive Officer at Alignment Healthcare (ALHC), 2021–2026.
The 87 reported transactions were 77 open-market sales, 6 stock awards, 2 tax withholdings and 1 open-market purchase, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $497K and 51 sales worth about $142.6M.
The only open-market purchase was 103,000 shares of ALHC at an average $4.82 on March 14, 2024, about $497K. Twelve months later ALHC was up 228%.
The largest open-market sale was 605,648 shares of ALHC at an average $18.74 on December 29, 2025, about $11.4M.
29 of the 35 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 6 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 27,400 | $13.00 | $356,200.00 | -4.4% | - | - | |
| Sep 11, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 557,870 | $12.77 | $7,121,670.84 | -31.3% | - | - | |
| Aug 10, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 298,000 | $13.88 | $4,136,776.40 | -27.4% | - | - | |
| Jul 10, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 298,000 | $19.86 | $5,919,361.02 | -21.5% | -56.1% | - | |
| Jun 10, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 298,000 | $20.36 | $6,066,620.78 | -17.7% | -34.5% | - | |
| May 11, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 298,000 | $16.89 | $5,032,849.76 | -16.5% | -19.7% | - | |
| Apr 13, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 298,000 | $20.68 | $6,161,942.61 | -14.2% | -2.9% | - | |
| Apr 7, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 250,000 | $21.01 | $5,252,910.60 | -10.6% | +13.4% | - | |
| Mar 23, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell10b5-1 | 118,000 | $17.48 | $2,062,439.40 | -4.8% | +21.6% | - | |
| Mar 18, 2026 | ALHC Alignment Healthcare, Inc. | Chief Executive Officer | Sell | 73,046 | $17.84 | $1,303,140.64 | -3.9% | +13.2% | - |